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Abstract: Naked mole-rats are long-lived animals that show unusual resistance to hypoxia, cancer
and ageing. Protein deimination is an irreversible post-translational modification caused by the
peptidylarginine deiminase (PAD) family of enzymes, which convert arginine into citrulline in
target proteins. Protein deimination can cause structural and functional protein changes, facilitating
protein moonlighting, but also leading to neo-epitope generation and effects on gene regulation.
Furthermore, PADs have been found to regulate cellular release of extracellular vesicles (EVs), which
are lipid-vesicles released from cells as part of cellular communication. EVs carry protein and genetic
cargo and are indicative biomarkers that can be isolated from most body fluids. This study was
aimed at profiling deiminated proteins in plasma and EVs of naked mole-rat. Key immune and
metabolic proteins were identified to be post-translationally deiminated, with 65 proteins specific
for plasma, while 42 proteins were identified to be deiminated in EVs only. Using protein-protein
interaction network analysis, deiminated plasma proteins were found to belong to KEEG (Kyoto
Encyclopedia of Genes and Genomes) pathways of immunity, infection, cholesterol and drug
metabolism, while deiminated proteins in EVs were also linked to KEEG pathways of HIF-1 signalling
and glycolysis. The mole-rat EV profiles showed a poly-dispersed population of 50–300 nm, similar
to observations of human plasma. Furthermore, the EVs were assessed for three key microRNAs
involved in cancer, inflammation and hypoxia. The identification of post-translational deimination of
critical immunological and metabolic markers contributes to the current understanding of protein
moonlighting functions, via post-translational changes, in the longevity and cancer resistance of
naked mole-rats.
Keywords: peptidylarginine deiminases (PADs); protein deimination; naked mole-rat (Heterocephalus
glaber); extracellular vesicles (EVs); immunity; metabolism; microRNA (miR21; miR155; miR210)
Int. J. Mol. Sci. 2019, 20, 5378; doi:10.3390/ijms20215378 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 5378 2 of 20
1. Introduction
Peptidylarginine deiminases (PADs) are phylogenetically conserved calcium-dependent enzymes
that post-translationally convert arginine into citrulline in target proteins in an irreversible manner.
This can cause structural changes in target proteins and affect protein function, gene regulation and
generation of neoepitopes [1–6]. Such post-translational changes in proteins may also allow for
protein moonlighting, an evolutionary acquired phenomenon facilitating proteins to exhibit several
physiologically relevant functions from within one polypeptide chain [7,8].
PADs and associated protein deimination are crucial players in cancer, autoimmune and
neurodegenerative diseases [4–6,9], with recent indications also for PAD-mediated mechanisms
in ageing [10]. Furthermore, critical roles have been identified for PADs and PAD-mediated protein
deimination in response to hypoxia and in CNS regeneration [11–15] as well as in tissue remodelling
and immunity [16–18]. Importantly, PADs have been found to have key roles in the regulation of
extracellular vesicle (EV) release [19–22]. EVs are found in most body fluids and participate in cellular
communication via transfer of cargo proteins and genetic material [6,23–26]. EVs isolated from serum,
plasma and other body fluids can therefore be useful health biomarkers [27,28]. Hitherto, work on EVs
has mainly been in the context of human pathologies and recent comparative immunology studies
on EVs and EV cargo have been performed [29], including the assessment of deiminated EV protein
cargo [30–32].
PADs have been identified throughout phylogeny from bacteria to mammals, with five tissue
specific PAD isozymes in mammals, three in chicken, one in bony and cartilaginous fish [1,16,17,31,33]
and PAD homologues in parasites [34], fungi [35] and bacteria [22]. While five PAD isozymes have
been described in the naked mole-rat (PADI1, Gene ID: 101722077; PADI2, Gene ID: 101721485; PADI3,
Gene ID: 101722435; PADI4, Gene ID: 101722785; PADI6, Gene ID: 101723122), no studies have been
carried out on their deiminated protein products or the putative physiological relevance of such
post-translational deimination in the physiology of the naked mole-rat.
The naked mole-rat is a burrowing rodent and eusocial mammal, and the only species in the
genus Heterochephalus of the family Heterochepalidae [36,37]. They have a set of highly unusual physical
traits, many of which are thought to derive from their highly-social and putatively hypoxic and
hypercapnic subterranean lifestyle. For example, naked mole-rats are among the most hypoxia-tolerant
mammal presently identified and tolerate minutes of anoxia, hours at 3% O2, and days to weeks at 8%
O2 [38–41]. The key to tolerating prolonged hypoxia is to match metabolic demand to reduced energy
(O2) supply [42–45], and in acute severe hypoxia (3% O2), the metabolic rate of adult naked mole-rats
decreases up to 85% [40]. However, naked mole-rats remain conscious and active, albeit to a reduced
degree [46–48]. These findings indicate that naked mole-rats are capable of significant metabolic
plasticity within their natural environment. Conversely, naked mole-rats are largely non-responsive
to hypercapnia and associated acidity-related pain responses are largely absent [49,50]. Naked
mole-rats also have numerous adaptations that are not as obviously linked to their natural habitat,
including a remarkable resistance to cancer [51,52], they are the only mammalian thermo-conformer
and almost entirely ectothermic for regulation of body temperature [53,54] and they have remarkable
longevity [55–58]. These traits make the naked mole-rat an important animal model for a range
of human diseases and for furthering understanding of pathways underlying cancer resistance
and longevity [59–61]. However, little is known about the immune system of naked mole-rats.
As PAD-mediated pathways and EVs are increasingly recognized as key players in immune responses
and metabolism, and related to a range of human inflammatory pathologies and cancer, a study on
these parameters in mole-rat is warranted.
In the current study, plasma and plasma-derived EVs were profiled in naked mole-rats and
assessed for deiminated protein profiles as well as three key microRNAs (miRs) related to inflammation
and hypoxic resistance. For the first time we report on post-translational deimination of key immune
and metabolic proteins in naked mole-rat and species-specific EV profiles.
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2. Results
2.1. PAD Homologues in Naked Mole-Rat Plasma
Using PAD-isozyme specific antibodies, generated against human PADs, positive bands were
observed by Western blotting and indicated PAD homologue proteins in mole-rat plasma at the
expected size of approximately 70–75 kDa for PAD2, PAD3 and PAD4 (Figure 1A).
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Figure 1. Peptidylarginine deiminases (PADs) and deiminated proteins in naked mole-rat plasma
and plasma-extracellular vesicles (EVs). (A) PAD positive bands were identified at the expected size
of approximately 70–75 kDa using the human PAD2, PAD3 and PAD4 specific antibodies in naked
mole-rat plasma. (B) Total deiminated proteins were identified in naked mole-rat plasma (n = 4)
using the F95 pan-deimination specific antibody. (C) Total deiminated proteins were identified in
naked mole-rat plasma-EVs using the F95 pan-deimination specific antibody (EV pools from plasma of
4 individuals are shown, respectively). (D) The F95-enriched IP fraction from mole-rat plasma (from a
pool of 5 individual mole-rat plasma; F95_IP) is shown. The molecular weight marker is indicated next
to each blot.
2.2. Deiminated Protein Profiles of Naked Mole-Rat Plasma and Plasma-Derived EVs
Total deiminated proteins were detected by Western blotting with the pan-deimination F95
antibody in mole-rat plasma and plasma-derived EVs, revealing a range of proteins mainly between
50–150 kDa (Figure 1B). The mono-specific F95 antibody was used in this study for the identification of
deiminated proteins, as it has been developed against a deca-citrullinated peptide and is predicted
to react with all deiminated/citrullinated proteins based on 100% sequence homology (MABN328
Merck), and it has been used to identify deiminated proteins in human and animals from diverse
taxa [11,12,16,18,19,21,22,31]. Deiminated proteins in mole-rat were also detected in the plasma-derived
EVs, mainly in the size range of 20–100 kDa (Figure 1C). Deiminated protein candidates in plasma
and EVs were further identified by F95 enrichment (see F95 enriched fraction from plasma assessed
by Western blotting, Figure 1D) and LC-MS/MS analysis (Tables 1 and 2; Supplementary Tables S1
and S2). In plasma, 112 species-specific protein hits were identified (Table 1 and Supplementary
Table S1) while in EVs, 80 protein hits were identified (Table 2 and Supplementary Table S2). Overall,
48 proteins overlapped between plasma and plasma-derived EVs, while 65 proteins were specific
for whole plasma only and 42 proteins for EVs only (Figure 2). The protein lists for deiminated
proteins identified in naked mole-rat plasma and plasma-EVs were submitted to STRING (Search Tool
for the Retrieval of Interacting Genes/Proteins) analysis (https://string-db.org/) to predict putative
protein-protein interaction networks (Figures 3 and 4).
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Table 1. Deiminated proteins identified by F95 enrichment in total plasma of naked mole-rat
(Heterocephalus glaber). Deiminated proteins were isolated by immunoprecipitation using the
pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak
list files were submitted to mascot. Species-specific peptide sequence hits scoring with H. glaber are
included and total score is shown. Protein hits identified in whole plasma only (but not in plasma EVs)
are highlighted in pink. For full LC-MS/MS data analysis see Supplementary Table S1.
Protein Name Symbol Total Score (p < 0.05) #
Apolipoprotein B-100 G5AZB7_HETGA 6077
Alpha-2-macroglobulin G5BPM1_HETGA 4974
Complement C3 G5C0N5_HETGA 4300
Serotransferrin G5BQA9_HETGA 4058
Serum albumin G5B5P2_HETGA 3394
Fibronectin G5BHR4_HETGA 3333
Fibrinogen beta chain G5BML3_HETGA 2638
Kininogen-1 G5BT86_HETGA 2276
Fibrinogen alpha chain G5BML2_HETGA 2094
Ceruloplasmin G5BSL1_HETGA 2022
Histidine-rich glycoprotein G5BT87_HETGA 1851
Complement C4-A G5C3H6_HETGA 1759
Complement factor H G5BM71_HETGA 1646
Plasminogen G5BC53_HETGA 1548
Inter-alpha-trypsin inhibitor heavy chain H4 G5BUN4_HETGA 1455
Fibrinogen gamma chain G5BML1_HETGA 1338
Complement factor B G5C3H1_HETGA 1313
Plasma kallikrein G5BNV2_HETGA 1167
Antithrombin-III G5ARS6_HETGA 1093
Coagulation factor V G5CB46_HETGA 1092
Complement C5 G5AXS5_HETGA 1002
Hemoglobin subunit beta G5BS33_HETGA 941
Transcobalamin-2 isoform 1 G5AVP0_HETGA 913
Hemopexin G5BBR0_HETGA 899
Coagulation factor XIII B chain G5BM72_HETGA 821
Protein AMBP G5B1Y4_HETGA 817
N-acetylmuramoyl-L-alanine amidase G5BYP3_HETGA 812
Coagulation factor XII G5BQ09_HETGA 802
Apolipoprotein A-I APOA1_HETGA 798
Hemoglobin subunit alpha G5BXY1_HETGA 784
Coagulation factor XIII A chain G5BAS8_HETGA 779
Hemoglobin subunit beta G5BYJ8_HETGA 759
Alpha-1-antiproteinase S G5B496_HETGA 724
Inter-alpha-trypsin inhibitor heavy chain H3 G5BUN3_HETGA 682
Vitronectin G5BVN8_HETGA 652
Complement factor I G5AQM1_HETGA 647
Hemoglobin subunit epsilon-1 G5BS35_HETGA 642
Inter-alpha-trypsin inhibitor heavy chain H2 G5AXV8_HETGA 584
Apolipoprotein E G5CBM7_HETGA 581
Inhibitor of carbonic anhydrase G5BQB0_HETGA 537
Inter-alpha-trypsin inhibitor heavy chain H1 G5BUN2_HETGA 482
Four and a half LIM domains protein 1 G5CA61_HETGA 469
Haptoglobin G5B5U6_HETGA 464
C4b-binding protein G5BP10_HETGA 438
L-lactate dehydrogenase G5AKA3_HETGA 437
Insulin-like growth factor-binding protein complex acid labile chain G5BY64_HETGA 403
Catalase G5AXV0_HETGA 382
Fetuin-B G5BT88_HETGA 347
Alpha-2-HS-glycoprotein G5BT89_HETGA 337
Selenoprotein P G5APA7_HETGA 328
Vitamin D-binding protein G5BE53_HETGA 317
Adiponectin G5BT83_HETGA 283
von Willebrand factor G5CAN6_HETGA 274
Beta-2-glycoprotein 1 G5BGY7_HETGA 268
Basement membrane-specific heparan sulfate proteoglycan core protein G5BI06_HETGA 267
Gelsolin G5AXS0_HETGA 259
Aspartyl aminopeptidase G5AKJ4_HETGA 256
Complement C1q subcomponent subunit A G5BHZ8_HETGA 246
Ficolin-3 G5AUT5_HETGA 241
Mannan-binding lectin serine protease 1 G5BTD5_HETGA 228
Alpha-1-antichymotrypsin G5B491_HETGA 228
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Table 1. Cont.
Protein Name Symbol Total Score (p < 0.05) #
Carboxypeptidase N catalytic chain G5AYP3_HETGA 210
Complement C1q subcomponent subunit C G5BHZ7_HETGA 191
Mannan-binding lectin serine protease 2 G5C521_HETGA 188
Prothrombin G5ATC4_HETGA 177
Complement C1q tumour necrosis factor-related protein 3 G5BQ97_HETGA0 177
Nucleoside diphosphate kinase G5C4L3_HETGA 168
L-lactate dehydrogenase G5BEG2_HETGA 167
Alpha-2-antiplasmin G5BCV1_HETGA 164
Keratin, type II cytoskeletal 6B G5ALS1_HETGA 152
Carbonic anhydrase 2 G5ATW7_HETGA 143
Proprotein convertase subtilisin/kexin type 9 G5APQ4_HETGA 137
Angiotensinogen G5BQI5_HETGA 121
6-phosphogluconate dehydrogenase, decarboxylating G5C530_HETGA 91
Nesprin-1 G5C0E1_HETGA 87
Complement C1q subcomponent subunit B G5BHZ6_HETGA 87
Angiopoietin-related protein 6 G5B341_HETGA 85
Hepatocyte growth factor activator G5BZF5_HETGA 84
Calpain-1 catalytic subunit G5B6L3_HETGA 84
Sulfhydryl oxidase G5AYL7_HETGA 80
Keratin, type II cytoskeletal 5 G5ALS3_HETGA 76
Profilin G5BH50_HETGA 75
40S ribosomal protein S27a G5B8W4_HETGA 68
Xanthine dehydrogenase/oxidase G5B3Z0_HETGA 68
Plasma protease C1 inhibitor G5BLJ5_HETGA 67
Collectin-11 G5C7L1_HETGA 66
Extracellular matrix protein 1 G5BH40_HETGA 64
Actin, gamma-enteric smooth muscle G5AXH0_HETGA 61
Collectin-10 G5C9R8_HETGA 61
Keratin, type I cytoskeletal 17 G5B0M4_HETGA 58
Contactin-1 G5BGJ6_HETGA 55
Dynein heavy chain 1, axonemal G5BUL8_HETGA 50
Leucine-rich repeat-containing protein 15 G5ALE6_HETGA 43
Transcriptional regulator ATRX G5C0I5_HETGA 42
Transmembrane protein 127 G5BMW1_HETGA 41
TRAF3-interacting protein 1 G5BHH8_HETGA 41
Mannose-binding protein A G5C4H7_HETGA 40
Hyaluronan-binding protein 2 G5BKD5_HETGA 39
Fer3-like protein G5BZJ1_HETGA 38
Complement component C7 G5C4R4_HETGA 38
PITH domain-containing protein G5BHY3_HETGA 38
1,4-alpha-glucan-branching enzyme G5BA56_HETGA 37
tRNA pseudouridine synthase G5BB54_HETGA 37
SRRM2-like protein G5BG61_HETGA 34
Putative carboxypeptidase PM20D1 G5BX50_HETGA 34
Olfactory receptor G5C741_HETGA 33
Protein CASC5 G5BLZ4_HETGA 33
Conserved oligomeric Golgi complex subunit 1 G5B5M3_HETGA 32
Small G protein signalling modulator 1 G5BGN5_HETGA 32
Eukaryotic translation initiation factor 3 subunit E G5BD61_HETGA 31
HEAT repeat-containing protein 2 G5AZ15_HETGA 31
Proline-rich protein 11 G5AXY5_HETGA 31
Peroxiredoxin-1 G5ARW1_HETGA 30
Pre-mRNA-processing factor 17 G5B0Y2_HETGA 30
Ribonucleoside-diphosphate reductase G5B9C2_HETGA 30
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Table 2. Deiminated proteins identified by F95 enrichment in plasma-derived EVs of naked
mole-rat (Heterocephalus glaber). Deiminated proteins were isolated by immunoprecipitation using the
pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak list files
were submitted to mascot. Species-specific peptide sequence hits scoring with H. glaber are included
and total score is shown. Protein hits identified in plasma-EVs only are highlighted in blue. For full
LC-MS/MS data analysis see Supplementary Table S2.
Protein Name Symbol Total Score (p < 0.05) #
Alpha-2-macroglobulin G5BPM1_HETGA 2978
Serum albumin G5B5P2_HETGA 2570
Serotransferrin G5BQA9_HETGA 1976
Keratin, type II cytoskeletal 6B G5ALS1_HETGA 1459
Complement C3 G5C0N5_HETGA 1440
Keratin, type II cytoskeletal 5 G5ALS3_HETGA 1211
Kininogen-1 G5BT86_HETGA 1196
Histidine-rich glycoprotein G5BT87_HETGA 1186
Keratin, type I cytoskeletal 10 G5AX66_HETGA 1130
Keratin, type I cytoskeletal 14 G5B0M6_HETGA 1038
Keratin, type II cytoskeletal 1 G5ALS8_HETGA 1011
Fibrinogen beta chain G5BML3_HETGA 974
Fibrinogen alpha chain G5BML2_HETGA 956
Apolipoprotein B-100 G5AZB7_HETGA 834
Keratin, type I cytoskeletal 13 G5B0N0_HETGA 701
Keratin, type I cytoskeletal 17 G5B0M4_HETGA 673
Desmoplakin G5BAT4_HETGA 670
Hemoglobin subunit alpha G5BXY1_HETGA 591
Hemoglobin subunit beta G5BS33_HETGA 581
Complement C4-A G5C3H6_HETGA 571
Hemoglobin subunit beta G5BYJ8_HETGA 568
Apolipoprotein A-I APOA1_HETGA 499
Keratin, type II cytoskeletal 79 G5BJ37_HETGA 468
Actin, cytoplasmic 1 G5BI78_HETGA 444
Keratin, type II cytoskeletal 4 G5BJ36_HETGA 443
Fibrinogen gamma chain G5BML1_HETGA 382
Ceruloplasmin G5BSL1_HETGA 350
Apolipoprotein E G5CBM7_HETGA 338
Inter-alpha-trypsin inhibitor heavy chain H4 G5BUN4_HETGA 332
Protein AMBP G5B1Y4_HETGA 280
Inhibitor of carbonic anhydrase G5BQB0_HETGA 244
Hemopexin G5BBR0_HETGA 239
Histone H4 G5BKL3_HETGA 238
Plasminogen G5BC53_HETGA 232
Alpha-1-antiproteinase S G5B496_HETGA 217
Hemoglobin subunit epsilon-1 G5BS35_HETGA 213
Junction plakoglobin G5B0M0_HETGA 202
N-acetylmuramoyl-L-alanine amidase G5BYP3_HETGA 190
Inter-alpha-trypsin inhibitor heavy chain H3 G5BUN3_HETGA 190
Keratin, type II cytoskeletal 7 G5BL96_HETGA 182
Fibronectin G5BHR4_HETGA 164
Glyceraldehyde-3-phosphate dehydrogenase G5CAP7_HETGA 154
Coagulation factor XII G5BQ09_HETGA 152
Antithrombin-III G5ARS6_HETGA 150
Catenin beta-1 G5ALX2_HETGA 126
Plakophilin-1 G5B3A4_HETGA 120
Annexin G5AWC0_HETGA 119
Keratin, type II cytoskeletal 3 G5ALT2_HETGA 118
40S ribosomal protein S27a G5B8W4_HETGA 116
Inter-alpha-trypsin inhibitor heavy chain H2 G5AXV8_HETGA 106
Alpha-2-antiplasmin G5BCV1_HETGA 86
Complement factor B G5C3H1_HETGA 81
Elongation factor 1-alpha G5ALK7_HETGA 78
Angiotensinogen G5BQI5_HETGA 77
Histone H2B G5BH20_HETGA 77
Plasma kallikrein G5BNV2_HETGA 72
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Table 2. Cont.
Protein Name Symbol Total Score (p < 0.05) #
Beta-enolase G5BW96_HETGA 70
Vitamin D-binding protein G5BE53_HETGA 57
Alpha-1-antichymotrypsin G5B491_HETGA 55
Keratin, type II cytoskeletal 80 G5BL95_HETGA 53
Heat shock cognate 71 kDa protein G5B170_HETGA 51
Leucine-rich repeat-containing protein KIAA1731 G5C3Y1_HETGA 50
Cathepsin D G5C2G1_HETGA 49
Basement membrane-specific heparan sulfate
proteoglycan core protein G5BI06_HETGA 47
Skin-specific protein 32 G5BUY9_HETGA 46
Desmocollin-1 G5C312_HETGA 46
Protein-arginine deiminase type-6 G5BZN1_HETGA 46
Cryptochrome-1 G5C454_HETGA 45
Complement C1q subcomponent subunit C G5BHZ7_HETGA 45
p2Y purinoceptor 12 G5C102_HETGA 44
Alpha-1B-glycoprotein G5B7K8_HETGA 44
Exportin-1 G5C1Y9_HETGA 44
Putative hexokinase HKDC1 G5B183_HETGA 43
Transcriptional regulator ATRX G5C0I5_HETGA 42
Coiled-coil domain-containing protein 57 G5BJ98_HETGA 42
Microtubule plus-end tracking protein TIP150 G5ATU1_HETGA 40
Tubulin alpha-1C chain G5AQ00_HETGA 38
Fer3-like protein G5BZJ1_HETGA 38
Amino acid transporter G5BYQ9_HETGA 36
Ventricular zone-expressed PH domain-containing
protein-like protein 1 G5B253_HETGA 35
SRRM2-like protein G5BG61_HETGA 35
N6-adenosine-methyltransferase 70 kDa subunit G5BFU9_HETGA 33
Proline-rich protein 11 G5AXY5_HETGA 33
Carbonic anhydrase 2 G5ATW7_HETGA 32
26S proteasome non-ATPase regulatory subunit 3 G5BRY1_HETGA 31
Serine/threonine-protein kinase LATS1 G5BMD1_HETGA 31
Transmembrane gamma-carboxyglutamic acid
protein 1 G5C418_HETGA 31
Collagen alpha-2(I) chain G5ANK8_HETGA 31
Bcl-2-associated transcription factor 1 G5C1A7_HETGA 30
# Ions score is −10 * Log(p), where p is the probability that the observed match is a random event. Individual ions
scores > 30 indicated identity or extensive homology (p < 0.05). Protein scores were derived from ions scores as a
non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 30. Protein hits identified in whole
plasma only (but not in plasma EVs) are highlighted in blue.
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 8 of 21 
 
 
Figure 2. Deiminated proteins identified in naked mole-rat plasma and plasma-EVs. Species specific 
hits identified for deiminated proteins in naked mole-rat plasma and EVs showed 112 total proteins 
identified in plasma and 80 in EVs, respectively. Of these, 48 protein hits were overlapping, while 64 
proteins were specific for whole plasma and 32 for plasma-EVs only, respectively. 
 
Figure 2. Deiminated proteins identified in naked mole-rat plasma and plasma-EVs. Species specific
hits identified for deiminated proteins in naked mole-rat plasma and EVs showed 112 total proteins
identified in plasma and 80 in EVs, respectively. Of these, 48 protein hits were overlapping, while
64 proteins were specific for whole plasma and 32 for plasma-EVs only, respectively.
Int. J. Mol. Sci. 2019, 20, 5378 8 of 20
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 8 of 21 
 
 
Figure 2. Deiminated proteins identified in naked mole-rat plasma and plasma-EVs. Species specific 
hits identified for deiminated proteins in naked mole-rat plasma and EVs showed 112 total proteins 
identified in plasma and 80 in EVs, respectively. Of these, 48 protein hits were overlapping, while 64 
proteins were specific for whole plasma and 32 for plasma-EVs only, respectively. 
 
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 9 of 21 
 
 
Figure 3. Protein-protein interaction networks of deiminated proteins identified in naked mole-rat 
plasma. Reconstruction of protein-protein interactions based on known and predicted interactions 
using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis. (A) Coloured 
nodes represent query proteins and first shell of interactors. (B) KEGG (Kyoto Encyclopedia of Genes 
and Genomes) pathways relating to the identified proteins and reported in STRING are highlighted 
as follows: red = complement and coagulation cascade; dark green = Staphylococcus aureus infection; 
purple = pertussis; yellow = platelet activation; light blue = systemic lupus erythematosus (SLE); 
orange = prion diseases; dark blue = cholesterol metabolism; light green = vitamin digestion and 
absorption; dark red = ferroptosis; pink = drug metabolism. Coloured nodes represent query proteins 
and first shell of interactors; white nodes are second shell of interactors. Coloured lines indicate 
whether protein interactions are identified via known interactions (curated databases, 
experimentally determined), predicted interactions (gene neighbourhood, gene fusion, gene 
co-occurrence) or via text mining, co-expression or protein homology (see the colour key for 
connective lines included in the figure). 
Figure 3. Protein-protein interaction networks of dei inated proteins identified in naked mole-rat
plasm . Reconstruction of protein-protein int r ti s based on known and predicted interactions
using STRING (Search Tool for the Retrieval of Inter enes/Proteins) analysis. (A) Coloured
nodes represent query proteins and first shell of int . (B) KE G (Ky to Encyclopedia of Genes
and Genomes) pathways relating to the identifie r t i s and reported in STRING are ig lighted
as follows: red = complement and coagulation cascade; dark green = Staphylococcus aureus infection;
purple = pertussis; yellow = platelet activation; light blue = systemic lupus erythematosus (SLE);
orange = prion diseases; dark blue = cholesterol metabolism; light green = vitamin digestion and
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text mining, co-expression or protein homology (see the colour key for connective lines included in
the figure).
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(B) KEGG pathways relating to the identified proteins and reported in STRING are highlighted as
follows: red = complement and coagulation cascade; dark green = Staphylococcus aureus infection; purple
= HIF-signalling pathway; yellow = platelet activation; light blue = systemic lupus erythematosus
(SLE); orange = oestrogen signalling pathway; dark blue = cholesterol metabolism; light green =
vitamin digestion and absorption; pink = glycolysis/gluconeogenesis. Coloured nodes represent query
proteins and first shell of interactors, white nodes are second shell of interactors. Coloured lines indicate
whether protein interactions are identified via known interactions (curated databases, experimentally
determined), predicted interactions (gene neighbourhood, gene fusion, gene co-occurrence) or via
text mining, co-expression or protein homology (see the colour key for connective lines included in
the figure).
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2.3. Characterisation of Extracellular Vesicles in Naked Mole-Rat Plasma
EVs isolated from naked mole-rat plasma were characterised for size distribution using
nanoparticle tracking analysis (NTA; Figure 5A), by Western blotting using EV-specific markers
(Figure 5B) and by morphological analysis using transmission electron microscopy (TEM; Figure 5C).
A poly-dispersed population of EVs mainly in the size range of 50 to 300 nm was observed, with some
variations between individual animals (Figure 5A), and also with respect to EV yield from plasma
(Figure 5D) and modal EV size (Figure 5E). Overall, the main EV peaks were detected at approximately
100–140 nm (Figure 5A,E), with the modal size of EVs falling mainly in the range of 90–115 nm,
although this varied somewhat between animals and some outliers were detected (Figure 5E). Western
blotting confirmed that the naked mole-rat EVs were positive for the EV-specific markers CD63 and
Flot-1 (Figure 5B). Typical EV morphology was confirmed by TEM (Figure 5C).
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Figure 5. Extracellular vesicle profiling in naked ole-rat plas a. (A) Nanoparticle tracking analysis
(NTA) shows a size distribution of EVs from naked mole-rat in the range of mainly 50 to 300 nm, with
representative NTA profiles of EVs from 3 different animals (NTA-1, NTA-2, NTA-3). (B) Western
blotting analysis confirms that naked mole-rat EVs are positive for the phylogenetically conserved
EV-specific markers CD63 and Flot-1. (C) Transmission electron microscopy (TEM) analysis of naked
mole-rat plasma-derived EVs shows typical EV morphology; a composite figure is shown and the
scale bar (100 nm) applies for all images in the panel. (D) EV yield in plasma of 12 individual naked
mole-rats is shown. (E) EV modal size in plasma of 12 individual naked mole-rats is presented.
2.4. MicroRNA Analysis of Naked Mole-Rat EVs
EVs isolated from naked mole-rat plasma were assessed for the relative expression of the immune-
and cancer-related miR21, the inflammatory-related miR155 and the metabolic- and hypoxia-related
miR210. The highest relative miR levels of the three miRs tested, were observed for miR21 in naked
mole-rat plasma-EVs, 394-fold higher than for miR155 and 153-fold higher than for miR210, respectively
(Figure 6A). The relative expression of the hypoxia- and metabolic-related miR210 was 2.6–fold higher
than the inflammatory miR155 (Figure 6B), which overall showed comparatively the lowest relative
levels of expression of the three miRs tested (Figure 6A,B).
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3. Discussion
For the first time, post-translationally deiminated proteins are described in naked mole-rat
(Heterocephalus glaber) plasma, unravelling novel aspects of post-translational deimination of key
proteins involved in immune defences and metabolism. PAD homologues were identified in naked
mole-rat plasma by Western blotting via cross reaction with human PAD2, which is the phylogenetically
most conserved form of PAD [1,16,31]. PAD-positive protein bands were also observed for PAD3
and PAD4, via cross-reaction with PAD isozyme-specific human antibodies, at an expected size of
approximately 70 kDa, similar to that reported for other mammalian PADs. Such protein detection
corresponds with PAD isozymes that have been identified in the naked mole-rat genome (PADI1, Gene
ID: 101722077; PADI2, Gene ID: 101721485; PADI3, Gene ID: 101722435; PADI4, Gene ID: 101722785;
PADI6, Gene ID: 101723122). Deiminated proteins were detected and identified both in whole
plasma and in plasma-derived EVs. The identity of specific deimination protein candidates in plasma
and plasma-EVs was assessed using F95-enrichment in tandem with LC-MS/MS analysis. The F95
mono-specific antibody used in the current study was developed against a deca-citrullinated peptide
and has been verified to detect deiminated/citrullinated proteins in diverse taxa [11,12,16,18,19,21,22,31].
In the naked mole-rat, species-specific protein hits revealed 48 common deiminated proteins in plasma
and EVs by F95-enrichment, which included some key immune and metabolic related proteins, while
65 deiminated protein hits were specific for plasma and 42 deiminated protein hits specific for EVs only.
As assessed by STRING analysis, the PPI enrich ent p-value for deiminated proteins identified
in naked mole-rat plasma and as cargo in plasma-derived EVs was found to be <1.0 × 10−16 for
both. Such an enrichment value indicates that the identified network of proteins has significantly
more interactions than expected. Therefore, these deiminated proteins have more interactions among
themselves than would be expected for a random set of proteins of similar size, drawn from the
genome. Such an enrichment indicates that the proteins, as a group, are at least partially biologically
connected. Deiminated target proteins identified in whole naked mole-rat plasma belonged to the
following KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways: complement coagulation
cascade, platelet activation, cholesterol metabolism, vitamin digestion and adsorption, drug metabolism
as ell as bacterial infection (Staphylococcus aureus and pertussis), autoim unity (systemic lupus
erythematosus) and prion diseases (Figure 3B). Deiminated target proteins identified in EVs of
naked mole-rat plasma belonged to KEGG pathways of the complement coagulation cascade, platelet
activation, HIF- (hypoxia-inducible factor) signalling pathway, glycolysis/gluconeogenesis, cholesterol
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metabolism, vitamin digestion and adsorption, oestrogen signalling pathway, as well as bacterial
infection (Staphylococcus aureus) and autoimmunity (systemic lupus erythematosus) (Figure 4B).
Of interest is that deiminated protein candidates involved in KEGG-pathways for HIF-1-signalling,
the master regulator of oxygen homeostasis, seem enriched in the plasma-EVs, indicating a role for
EV-mediated transport of such proteins in hypoxic signalling. It is worth noting that naked mole-rats
have a high endogenous expression of HIF due to mutation in the VHL (Von Hippel-Lindau disease
tumor suppressor) domain [62], which could possibly explain the elevated HIF-1 signalling related
targets identified here. Furthermore, deiminated proteins identified in EVs were also enriched for
glycolysis and gluconeogenesis KEGG pathways. Our findings indicate that protein deimination
may play hitherto unidentified roles in the unusual hypoxia resistance and metabolism of the naked
mole-rat, including via EV-transport in cellular communication, also under normal physiological
conditions. In addition, the presence of deiminated histone H2B and H4 in EVs may be of some
interest as histone deimination is well known to contribute to epigenetic regulation including in
cancer [4,6], and the naked mole-rat has been found to have a particularly stable epigenome, which
may contribute to the cancer resistance and longevity observed in these animals [63]. Furthermore, an
abundance of deiminated complement components identified in both plasma and plasma-EVs may
indicate roles for functional diversity of the complement system via post-translational deimination
in the naked mole-rat. This may play various roles in naked mole-rat immune responses as recent
studies have identified some unusual characteristics, including atypical immune surveillance and
a greater reliance on myeloid-biased innate immunity [64]. Also noteworthy is the identification of
deiminated adiponectin in naked mole-rat plasma identified here, as adiponectin in humans is the most
abundant secreted adipokine with pleiotropic roles in metabolism [65,66], glucose regulation [67–69],
longevity [70], regeneration and cancer [71–73]. Such deimination of adiponectin has not been studied
and may add to some of its protein moonlighting function and be of relevance in the context of the
unusual metabolism of the naked mole-rat.
As part of EV-mediated cellular communication in physiology and pathologies, the transport
of microRNAs (miRs) is well acknowledged. There is increasing interest, reflected in a range of
studies, in furthering our understanding of how such EV-mediated transport may play a part in
physiological and pathophysiological processes. MiRs are highly conserved small non-coding RNAs
that control gene expression and regulate biological processes by targeting messenger RNAs (mRNAs).
MiRs can, for example, inhibit post-transcriptional translation of mRNA as well as enhance mRNA
degradation [74]. Some expression profiling has been carried out in naked mole-rats, mainly at the
transcriptome level [75,76], although no studies have assessed miRs in EVs of naked mole-rat plasma.
This study focused on assessing three key miRs known to be involved in cancer, inflammation and
hypoxia due to the unusual resistance of naked mole-rats to cancer, ageing and hypoxia. MiR21 is a
main immunoregulatory and onco-related miR and is also associated with chronic diseases [77–79].
MiR21 is strongly conserved throughout evolution and while many experimentally verified targets of
miR21 are tumour suppressors, miR21 is also linked to cardiac disease and oxidative stress [80]. Less is
known about the physiological roles of miR21. In the current study, miR21 was found to be by far
the highest miR expressed in EVs of naked mole-rat out of the three miRs tested. Roles for miR21 in
immune responses of naked mole-rat have not been reported in detail and the expression of miR21 in
EVs has not been assessed in naked mole-rat before.
In mammals, miR155 is known to be a major inflammatory related miR, linked to inflammatory
and stress responses [81]. Here, miR155 was found to be the least expressed of the three miRs tested
in naked mole-rat plasma-EVs, possibly indicating that this miR may be a contributing factor to the
“anti-inflammatory” state of mole-rats, which may have some relation to their longevity and cancer
resistance. MiR210 is known to be a major miR induced under hypoxia and has an important role in
mitochondrial metabolism, DNA damage response, cell proliferation and apoptosis [74]. MiR210 has
an important role in regulating mitochondrial metabolism [82] and cell glycolytic activity, as well as
being linked to inflammation [83]. MiR210 has been identified as a regulator of the hypoxia pathway
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and was found to have pro-apoptotic functions under normoxic conditions, but anti-apoptotic effects
under hypoxic conditions [84,85]. In the current study, miR210 was found to be more highly expressed
in mole-rat plasma than the inflammatory miR155. As naked mole-rats are known to be hypoxia
tolerant animals and to exhibit marked changes in their metabolic substrate use and metabolic demand
in hypoxia [41,86], miR210 may have functional roles in metabolic control, possibly contributing to
the well-known longevity of these animals. As this is the first study to assess the expression of these
three onco-, inflammatory- and metabolic-related miRs in naked mole-rat plasma-EVs, it remains to be
fully understood what specific functions the EV-mediated transport of these miRs play in the unusual
physiology of naked mole-rats.
Here, for the first time, we report the protein deimination profiles of plasma and plasma-derived
EVs in naked mole-rats. Post-translational deimination of major key immune and metabolic factors in
naked mole-rats was identified and related to key KEGG pathways of inflammation, metabolism and
oxygen transport. Our findings highlight novel aspects of protein moonlighting via post-translational
deimination, including via EV-mediated transport. Research on EVs is a relatively new field in
comparative animal models, and to our knowledge this is the first characterisation of EVs and
associated protein and selected miR cargo markers in naked mole-rats. Furthermore, as PADs
have been found to play major roles in the regulation of EV release [19–22,34], their contribution to
EV-mediated cell communication in response to physiological and pathophysiological changes in
naked mole-rats remains to be further investigated. Findings in long-lived mammals that display
cancer resistance, including naked mole-rats, may be of considerable translational value for furthering
our understanding of the mechanisms underlying cancer resistance for improved development of
human cancer therapies [59].
In continuation of the current study, the assessment of changes in deiminated proteins and EV
profiles, including protein and genetic EV-cargo, may be of great interest in studies using this unique
animal model to further understanding of the hitherto novel and understudied mechanisms involved
in cancer and ageing.
4. Materials and Methods
4.1. Sampling of Naked Mole-Rat Plasma
Naked mole-rats were group-housed in interconnected multi-cage systems at 30 ◦C and 21%
O2 in 50% humidity with a 12L:12D light cycle. Animals were fed fresh tubers, vegetables, fruit
and Pronutro cereal supplement ad libitum. Animals were not fasted prior to experimental trials.
All experimental procedures were approved by the University of Ottawa Animal Care Committee in
accordance with the Animals for Research Act and by the Canadian Council on Animal Care (protocol
# 2535). Non-breeding (subordinate) naked mole-rats do not undergo sexual development or express
sexual hormones and thus we did not take sex into consideration when evaluating our results [87].
Blood was collected from 12 adult (~ 1–2 years old) subordinate naked mole-rats following live cervical
dislocation and rapid decapitation. Blood was collected in Eppendorf tubes pre-coated with a 10%
EDTA (ethylenediaminetetraacetic acid) solution. Plasma was isolated by centrifugation at 5000× g for
5 min. The isolated plasma was aliquoted and immediately frozen at −80 ◦C until further use.
4.2. Extracellular Vesicle Isolation and Nanoparticle Tracking Analysis (NTA)
EVs were isolated by step-wise centrifugation according to our established protocols using
ultracentrifugation and the recommendations of MISEV2018 (the minimal information for studies of
extracellular vesicles 2018; [88]). Mole-rat plasma were diluted 1:4 in ultra-filtered (using a 0.22 µm
filter) Dulbecco’s PBS (100 µL plasma added to 400 µL DPBS) and then centrifuged at 4000× g for
30 min at 4 ◦C for removal of aggregates and apoptotic bodies. The supernatants were collected and
centrifuged further at 100,000× g for 1 h at 4 ◦C. The EV-enriched pellets were washed in 1 mL DPBS
and ultra-centrifuged at 100,000× g for 1 h at 4 ◦C. The final EV pellets were resuspended in 100 µL
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DPBS and frozen at −80 ◦C until further use. For NTA, based on Brownian motion of particles in
suspension, the EV pellets were diluted 1/100 in DPBS and applied to the NanoSight NS300 system
(Malvern Panalytical Ltd., Malvern, UK) in conjunction with a syringe pump to ensure continuous flow
of the sample. Five 60 sec videos were recorded for each sample, with approximately 40–60 particles
per frame, and the replicate histograms generated were averaged.
4.3. Transmission Electron Microscopy (TEM)
EVs were isolated from individual plasma as described above. For TEM, the EV pellets were
fixed with 2.5% glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.0) for 1 h at 4 ◦C. The
EVs were then resuspended in 100 mM sodium cacodylate buffer (pH 7.0), placed on to a grid with a
glow discharged carbon support film and stained with 2% aqueous Uranyl Acetate (Sigma-Aldrich,
Gillingham, UK). Individual EVs were imaged by TEM using a Morada CCD camera (EMSIS GmbH,
Münster, Germany) and processed via iTEM (EMSIS).
4.4. Western Blotting Analysis
Mole-rat plasma and plasma-EVs (an EV pellet derived from 100 µL plasma, reconstituted in
100 µL PBS) were diluted 1:1 in 2 × Laemmli sample buffer, boiled for 5 min at 100 ◦C and separated by
SDS-PAGE on 4–20% TGX gels (BioRad, Watford, UK). Approximately 5 µg protein was loaded per
lane. Following SDS-PAGE, proteins were transferred to nitrocellulose membranes using semi-dry
Western blotting; even transfer was assessed by PonceauS (Sigma-Aldrich, Gillingham, UK) staining.
The membranes were blocked in 5% BSA in TBS-T for 1 h at room temperature (RT) and thereafter
incubated with the following primary antibodies diluted in TBS-T: F95 pan-deimination antibody
(MABN328, Merck, Watford, UK, 1/1000); PAD2 (ab50257, Abcam, Cambridge, UK, 1/1000); PAD3
(ab50246, Abcam, 1/1000); PAD4 (ab50247, Abcam, 1/1000); and two EV-specific markers: CD63
(ab216130, Abcam, 1/1000); Flot-1 (ab41927, Abcam, 1/2000). After primary antibody incubation
overnight at 4 ◦C on a shaking platform, the membranes were washed for 3 × 10 min in TBS-T at RT
and thereafter incubated with the appropriate HRP-conjugated secondary antibodies (anti-rabbit IgG
BioRad or anti-mouse IgM BioRad, diluted 1/4000 in TBS-T) for 1 h, at RT. Membranes were washed
for 5 × 10 min in TBS-T, followed by 1 × 10 min in TBS proteins bands were visualised using enhanced
chemiluminescence (ECL, Amersham, Buckinghamshire, UK) and digital images were obtained using
the UVP BioDoc-ITTM System (Thermo Fisher Scientific, Hemel Hempstead, UK).
4.5. Immunoprecipitation and Protein Identification
Deiminated proteins in plasma and in plasma-derived EVs were immunoprecipitated by
enrichment with the F95 pan-deimination antibody (MABN328, Merck, Watford, UK), which has
been developed against a deca-citrullinated peptide and specifically detects proteins modified by
citrullination [89]. The mono-specific F95 antibody is predicted to react with all deiminated/citrullinated
proteins based on 100% sequence homology and has for example been used to identify deiminated
proteins in human, mouse, rat, chicken and teleost fish tissue [11,12,16,18,19,21,22,31,89]. The
Catch and Release immunoprecipitation kit (Merck, Watford, UK) was used according to the
manufacturer’s instructions. For F95 enrichment, plasma was pooled from 5 individual animals
(5 × 20 µL), while for EVs, total protein was first extracted from the EV pellets derived from 100
µL plasma per animal, using 100 µL RIPA + buffer on ice for 2 h followed by centrifugation at
16,000× g for 30 min to collect the supernatant containing the proteins. The immunoprecipitation was
carried out on a rotating platform overnight at 4 ◦C, and the F95 bound proteins were eluted using
denaturing elution buffer according to the manufacturer’s instructions (Merck). The F95 enriched
eluates were then either analysed by Western blotting or by liquid chromatography with tandem
mass spectrometry (LC-MS/MS; Cambridge Proteomics, Cambridge, UK). Peak files obtained were
submitted to Mascot (Matrix Science). An in-house database (Cambridge proteomics) for naked
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mole-rat was used for the identification of species-specific protein hits (CCP_Heterocephalus_glaber
Heterocephalus_glaber_20190911; 21449 sequences; 10466552 residues).
4.6. MicroRNA Analysis
EV isolates from individual naked mole-rat plasma (from 100 µL plasma as before) were assessed
for relative expression of 3 key microRNAs (miRs) related to oncogenic, inflammatory and metabolic
activity. These selected miRs included two cancer and immune-related miRs, miR21 and miR155,
and miR210 for hypoxia and metabolic activity. Total RNA was extracted from mole-rat plasma EVs
(prepared as before) using Trizol (Sigma-Aldrich, Gillingham, UK). The purity and concentration of
the isolated RNA were measured using the NanoDrop Spectrophotometer at 260 nm and 280 nm
absorbance. The cDNA was produced using the qScript microRNA cDNA Synthesis Kit (Quantabio,
Beverly, MA, USA) according to the manufacturer’s instructions and used to assess the expression of
miR21, miR155 and miR210. Reference RNAs used for the normalization of miR expression levels were
U6-snRNA and has-let-7a-5p. The PerfeCTa SYBR Green SuperMix (Quantabio, Beverly, MA, USA)
was used together with MystiCq microRNA qPCR primers for the miR21 (hsa-miR-21-5p), mir155
(hsa-miR-155-5p) and miR210 (hsa-miR-210-5p). All miR primers were obtained from Sigma-Aldrich
(UK). Thermocycling conditions were used as follows: denaturation at 95 ◦C for 2 min, followed by
40 cycles of 95 ◦C for 2 s, 60 ◦C for 15 s, and extension at 72 ◦C for 15 s. The 2∆∆Ct method [90] was used
for calculating relative miR expression levels and for normalisation. Each experiment was performed
in 3 individuals, in triplicate.
4.7. Statistical Analysis
The histograms and graphs were prepared using the Nanosigh NS300 software (Malvern
Panalytical Ltd., Malvern, UK) and GraphPad Prism version 7 (GraphPad Software, San Diego,
CA, USA). Experiments were repeated in triplicate, histograms represent mean of data and standard
error of mean (SEM) is indicated by the error bars. Significant differences were considered as p ≤ 0.05,
following one-way ANOVA or Student’s t-test.
5. Conclusions
Here, for the first time, we report the protein deimination profiles of plasma and plasma-derived
EVs in naked mole-rats. Post-translational deimination of major key immune and metabolic proteins in
naked mole-rats was identified and related to key KEGG pathways of inflammation, metabolism and
oxygen transport. Our findings highlight novel aspects of protein moonlighting via post-translational
deimination, including via EV-mediated transport of such proteins in cellular communication. Three
key microRNAs for oncogenic, inflammatory and metabolic/hypoxia function were also assessed in
mole-rat plasma EVs. In continuation of the current study, the assessment of changes in deiminated
proteins and EV profiles, including protein and microRNA EV-cargo may be of great interest in
studies using this unique animal model to further understanding of hitherto novel and understudied
mechanisms involved in cancer, inflammatory diseases and ageing.
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